Falk Gastro Info 10/2015

Video

 

Video course abdominal ultrasound

Patient in a standing position

 

Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.

© 2015 Falk Foundation e.V., Freiburg. All rights reserved.

 

 

Please switch on your loudspeakers!

 

 

Link to Falk Mediacenter:

http://media.falkfoundation.de/index.php?id=133&L=1

 

Link to the video directly:

http://media.drfalkpharma.de/fileadmin/media/18_Liver_Patient_in_a_standing_position_ENG.mp4

 

 

Preview images:

 

580 x 325 pixels (with arrow)

http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip18_580P.jpg

 

580 x 325 pixels (without arrow)

http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip18_580.jpg

 

 

 

 

Latest research in brief:

 

Description field (to be displayed at the end of the structural element):

 

 

Bowel

http://www.drfalkpharma.de/fileadmin/media/logos_falk/abstracts/Falk-Darm.png

 

 

Text:

Fréling E et al, Am J Gastroenterol. 2015;110(8):1186–96

Dermatological complications due to anti-TNF therapy in IBD: Although psoriasiform lesions and infections occur in approx. 20% of patients, therapy can be continued in the majority of patients.

 

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#29328

 

 

Text:

van Heijningen EM et al, Gut. 2015;64(10):1584–92

Adherence to surveillance guidelines after removal of colorectal adenomas: Only less than 25% of patients in a huge Dutch patient cohort received appropriate surveillance according to guidelines.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29330

 

 

Text:

Aziz I et al, Clin Gastroenterol Hepatol. 2015;13(9):1650–5.e2

Important differential diagnosis for diarrhea-predominant irritable bowel syndrome (IBS-D): 25% of patients with IBS-D according to Rome III criteria have idiopathic bile acid diarrhea which should therefore be excluded before diagnosing IBS-D.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29331

 

 

 


 

Liver
Biliary Tracts

http://www.drfalkpharma.de/fileadmin/media/logos_falk/abstracts/Falk-Leber.png

 

 

Text:

Charlton M et al, Gastroenterology. 2015;149(3):649–59

Hepatitis C: Ledipasvir and sofosbuvir plus ribavirin for 12 weeks lead to high rates of viral clearance even in patients with advanced liver cirrhosis. This therapy is very efficient even in patients with decompensated liver cirrhosis before or after liver transplantation.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29332

 

 

Text:

Sauerbruch T et al, Gastroenterology. 2015;149(3):660–8.e1

Liver cirrhosis: Prevention of rebleeding from esophageal varices by a small-diameter, covered transjugular intrahepatic portosystemic shunt (TIPS) is more effective than drug therapy. Treatment by TIPS did however not increase survival time or quality of life.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29333

 

 

Text:

Kushner T et al, J Hepatol. 2015;63(3):586–92

Hepatitis delta: Testing rates for hepatitis delta in chronic hepatitis B patients in the United States are inappropriately low (8.5%). All patients with chronic hepatitis B should be tested at least once for co-infection with hepatitis D virus.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29334

 

 

 

 


 

Oesophagus

Stomach

Duodenum

http://www.drfalkpharma.de/fileadmin/media/logos_falk/abstracts/Falk-Magen.png

 

 

Text:

Small AJ et al, Gastroenterology. 2015;149(3):567–76.e3

Therapy of Barrett’s esophagus with confirmed low-grade intraepithelial neoplasia: Radiofrequency ablation is associated with decreased neoplastic progression.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29335

 

 

Text:

Carroccio A et al, Gastroenterology. 2015;149(3):596–603.e1

Non-celiac wheat sensitivity: High proportions of patients have autoimmune disease and antinuclear antibodies.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29336

 

 

Text:

Chan EW et al, Gastroenterology. 2015;149(3):586–95.e3

Gastrointestinal bleeding related to dabigatran: PPI and H2-antagonists are associated with a reduced risk of upper gastrointestinal bleeding, in particular in patients with prior history of peptic ulcer disease or previous bleeding episodes.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29337

 

 

 

 

Pancreas

http://www.drfalkpharma.de/fileadmin/media/logos_falk/abstracts/Falk-Pankreas.png

 

 

Text:

Wu BU et al, Am J Gastroenterol. 2015;110(8):1233–9

Protective effects of statins in pancreatic carcinoma: Moderate- or high-dose therapy with simvastatin at baseline is associated with improved overall and disease-free survival.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20374#c29338

 

 

 


 

Falk Symposia

 

 

Falk Symposium 199

VIII Falk GASTRO-CONFERENCE (Part I)

Highlights from Hepatology 2015: From Chronic Hepatitis to Hepatocellular Carcinoma

 

Bild:

http://www.drfalkpharma.de/fileadmin/media/newsletter/symposium.gif

 

Text:

October 14 – 15, 2015, Freiburg, Germany

Konzerthaus Freiburg, Konrad-Adenauer-Platz 1, 79098 Freiburg, Germany

 

Link1:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/FS199_Freiburg_2015_Preliminary_Program.pdf

 

Link2:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/GastroConference_Freiburg_2015_Registration.pdf

 

Link für Online-Anmeldung:

http://events.drfalkpharma.de/index.php?id=105&L=1

 

 

 

Falk Symposium 200

VIII Falk GASTRO-CONFERENCE (Part II)

Therapeutic Strategies in Diseases of the Digestive Tract – 2015 and Beyond

 

Bild:

http://www.drfalkpharma.de/fileadmin/media/newsletter/symposium.gif

 

Text:

October 16 – 17, 2015, Freiburg, Germany

Konzerthaus Freiburg, Konrad-Adenauer-Platz 1, 79098 Freiburg, Germany

 

Link1:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/FS200_Freiburg_2015_Preliminary_Program.pdf

 

Link2:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/GastroConference_Freiburg_2015_Registration.pdf

 

Link für Online-Anmeldung:

http://events.drfalkpharma.de/index.php?id=105&L=1

 

 

 

 

Falk Workshop

Workshop on Gastrointestinal GVHD

 

Bild:

http://www.drfalkpharma.de/fileadmin/media/newsletter/falk_workshop.gif

 

Text:

November 13 – 14, 2015, Regensburg, Germany

University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany

 

Link1:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/WS_Regensburg_2015_Preliminary_Program.pdf

 

Link2:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/WS_Regensburg_2015_Registration.pdf

 

Link für Online-Anmeldung:

http://events.drfalkpharma.de/index.php?id=109&L=1

 

 

 

Workshop

Communications and System Relevance in Liver Damage and Regeneration

 

Bild:

http://www.drfalkpharma.de/fileadmin/media/newsletter/falk_workshop.gif

 

Text:

January 21 – 22, 2016, Düsseldorf, Germany

Building 23.01, Hörsaal 3D, Heinrich-Heine University, Universitätsstr. 1, 40225 Düsseldorf, Germany

 

Link1:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/WS_Duesseldorf_2016_Preliminary_Program.pdf

 

Link2:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/WS_Duesseldorf_2016_Registration.pdf

 

Link für Online-Anmeldung:

http://events.drfalkpharma.de/index.php?id=42&L=1

 

 

 

 

 

Symposium 201

Gut-Liver Interactions: From IBD to NASH

 

Bild:

http://www.drfalkpharma.de/fileadmin/media/newsletter/symposium.gif

 

Text:

March 11 – 12, 2016, Innsbruck, Austria

Congress Innsbruck, Rennweg 3, 6020 Innsbruck, Austria

 

Link1:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/FS201_Innsbruck_2016_Preliminary_Program.pdf

 

Link2:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposien_und_Workshops/FS201_Innsbruck_2016_Registration.pdf

 

Link für Online-Anmeldung:

http://events.drfalkpharma.de/index.php?id=205&L=1

 

 

 

 

Current Falk literature:

 

NEW

Falk Symposium report

Falk Symposium 196

Critical Evaluation of Current Concepts and Moving to New Horizons in the Management of IBD

Frankfurt (Germany), March 6 – 7, 2015

(36 pages)

FSR196e

 

Picture:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposium_Report/FSR196e.jpg

 

PDF:

http://www.drfalkpharma.de/fileadmin/media/Falk_Veranstaltungen/Falk_Symposium_Report/FR196e_Frankfurt_2015.pdf

 

 

 

Order by email (Please replace text by your email address):

 

mailto:text?subject=FGI%210%2F2015:%20Ordering%20of%20brochure%20FSR196e&body=Please%20send%20the%20brochure%20to%20the%20following%20address:%0A%0A